Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:VNO
NYSE:VNOOffice REITs

Is It Time To Reconsider Vornado Realty Trust (VNO) After Its Recent Share Price Slide?

For investors considering whether Vornado Realty Trust at around US$26.48 reflects enough potential or already embeds too much optimism, this article breaks down what the current share price really represents. The stock has had a mixed run, with a 1.7% gain over the last 7 days, an 8.8% decline over the last 30 days, a 20.8% decline year to date, a 29.9% decline over 1 year, and a 114.6% return over 3 years, compared with a 32.1% decline over 5 years. Recent coverage around Vornado Realty...
TSE:3774
TSE:3774Telecom

Does Internet Initiative Japan's (TSE:3774) New Safous Tool Clarify Its Cybersecurity Edge Or Stretch It?

Internet Initiative Japan Inc. recently launched an Internal Vulnerability Assessment service within its Safous Security Assessment offering, helping organizations identify security weaknesses across internal networks at branch offices and distributed locations. This move broadens the company’s role in cyber defense by pairing external attack surface assessment with internal network visibility, addressing rising concerns over supply chain attacks and limited on-site IT resources. We’ll now...
NasdaqCM:OVID
NasdaqCM:OVIDBiotechs

A Look At Ovid Therapeutics (OVID) Valuation After OV329 Trial Update And US$60 Million Financing

Ovid Therapeutics (OVID) has drawn fresh attention after reporting Phase 1 data for its OV329 epilepsy program at a 7 mg dose, alongside plans to expand into new seizure indications backed by about US$60 million in private financing. See our latest analysis for Ovid Therapeutics. The new OV329 data and US$60 million financing arrive after a sharp run in the stock, with a 30 day share price return of 60.84% and a 1 year total shareholder return above 400%, even though the 3 year and 5 year...
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

Collegium Pharmaceutical Expands ADHD Portfolio With AZSTARYS And Valuation Gap

Collegium Pharmaceutical (NasdaqGS:COLL) has entered into a definitive agreement to acquire AZSTARYS. The deal expands Collegium’s ADHD portfolio and secures longer-term product exclusivity for its ADHD offerings. The transaction is described as immediately accretive to adjusted EBITDA. For investors following the ADHD treatment space, this move provides another data point on how branded therapies are being repositioned. Collegium, which focuses on pain and ADHD treatments, is adding...
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

Is It Time To Reassess NBT Bancorp (NBTB) After Recent Share Price Weakness?

If you are wondering whether NBT Bancorp at around US$40.97 is starting to look interesting, the current share price and fundamentals raise some clear valuation questions worth unpacking. The stock has seen a 0.7% decline over the last week, a 10.4% decline over the past month, and a 1.5% decline year to date, while the 1 year, 3 year, and 5 year returns stand at a 1.9% decline, 34.7%, and 21.3% respectively. Recent attention on regional banks, regulatory capital expectations, and investor...
NYSE:GLOB
NYSE:GLOBIT

Globant Taps AI Cancer Research And Payments Deals As Shares Lag Targets

Globant (NYSE:GLOB) announced an AI focused collaboration with PharmaMar to support cancer drug discovery efforts. The company also agreed a global integration partnership with payments platform Adyen for enterprise clients. Both arrangements position Globant in healthcare and fintech projects tied to drug research and digital payments infrastructure. Globant operates as a digital services and technology company, working with enterprises that are investing in cloud, data and AI based...
SEHK:1313
SEHK:1313Basic Materials

China Resources Cement Holdings SEHK 1313 Margin Rebound Challenges Long Term Bearish Narratives

China Resources Building Materials Technology Holdings (SEHK:1313) has put fresh numbers on the table for FY 2025, with Q4 revenue of C¥5.99b and basic EPS of C¥0.022 helping to lift trailing twelve month EPS to C¥0.069 on revenue of C¥21.05b. Over recent quarters the company has seen quarterly revenue move between C¥4.63b and C¥5.99b, while basic EPS has ranged from C¥0.003 to C¥0.029. This gives investors a clearer view of how earnings are tracking through the year. With net profit margins...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Intuitive Machines (LUNR) Q4 Loss Of US$19.9 Million Tests Profitability Narrative

Intuitive Machines (LUNR) closed FY 2025 with Q4 revenue of US$44.8 million and a basic EPS loss of US$0.17, alongside a net loss of US$19.9 million, while on a trailing 12 month basis revenue was US$210.1 million and EPS stood at a loss of US$0.71 with a net loss of US$83.9 million. Over recent quarters, the company has seen quarterly revenue move from US$62.5 million in Q1 2025 to US$50.3 million in Q2, US$52.4 million in Q3 and US$44.8 million in Q4, with EPS losses ranging between US$0.06...
SEHK:6060
SEHK:6060Insurance

ZhongAn Online P & C Insurance (SEHK:6060) Net Income Surge Tests Bearish Margin Narratives

ZhongAn Online P & C Insurance (SEHK:6060) has just posted its FY 2025 first half numbers, with revenue of C¥15.8 billion and basic EPS of C¥0.45, set against trailing twelve month revenue of C¥36.4 billion and EPS of C¥0.70 that reflect the 82.5% earnings growth reported over the past year. The company has seen revenue move from C¥33.7 billion on a trailing basis in mid 2024 to C¥36.4 billion now, while EPS on the same basis has gone from C¥0.41 to C¥0.70, pointing to tighter earnings power...
SEHK:2367
SEHK:2367Personal Products

Giant Biogene Holding (SEHK:2367) Margin Compression Tests Bullish Growth Narratives

Giant Biogene Holding (SEHK:2367) has posted fresh FY 2025 numbers, with first half revenue at C¥3.1b and basic EPS at C¥1.14, setting the stage against trailing 12 month revenue of C¥6.1b and EPS of C¥2.25. The company has seen revenue move from C¥2.5b in 1H 2024 to C¥3.1b in 1H 2025, while basic EPS shifted from C¥0.99 to C¥1.14 over the same periods, providing a clear view of how the top and bottom line are tracking into the latest release. With a trailing net profit margin of 34.7% versus...
NYSE:UAMY
NYSE:UAMYMetals and Mining

United States Antimony Contracts Recast Critical Minerals And Tungsten Growth Story

United States Antimony (NYSE:UAMY) secured a U.S. government contract worth more than $248m for antimony ingots in the past week. The company reported an additional $354m in new antimony agreements, expanding its role in critical mineral supply chains. UAMY announced an acquisition of a tungsten asset in Ontario, targeting domestic tungsten production for North America. The company restarted antimony mining in Montana and is increasing processing capacity with active government...
TSE:8058
TSE:8058Trade Distributors

Is It Too Late To Consider Mitsubishi (TSE:8058) After Its Strong Share Price Run?

If you are wondering whether Mitsubishi's share price still offers value after a strong run, the key is to separate story from numbers and look closely at what the current price actually reflects. Mitsubishi last closed at ¥5,397, with 7 day returns of 5.4%, 30 day returns of 10.4%, year to date returns of 47.7%, 1 year returns of 97.6%, 3 year returns of 284.8%, and 5 year returns that are very large. This article was prompted to keep ongoing coverage of Mitsubishi current for investors, so...
SEHK:856
SEHK:856Electronic

VSTECS Holdings (SEHK:856) Earnings Growth Rebound Challenges Long Term Decline Narrative

VSTECS Holdings (SEHK:856) has reported its FY 2025 first half with revenue of HK$45.5b and basic EPS of HK$0.44, setting the tone for another busy earnings season in Hong Kong tech distribution. The company has seen revenue move from HK$40.1b and EPS of HK$0.33 in 1H 2024 to HK$49.0b and EPS of HK$0.43 in 2H 2024. Trailing twelve month EPS reached HK$0.98 on revenue of HK$97.6b, giving investors a clearer view of the company’s scale and margins heading into the new fiscal year. See our full...
SEHK:327
SEHK:327Electronic

PAX Global Technology (SEHK:327) Margin Improvement Challenges Long‑Running Earnings Decline Narrative

PAX Global Technology (SEHK:327) has opened FY 2025 with first half revenue of HK$2.7b and basic EPS of HK$0.37, setting the tone for how the year’s earnings story is shaping up. The company has seen revenue move from HK$3.0b in 1H 2024 to HK$2.7b in 1H 2025, while basic EPS shifted from HK$0.42 to HK$0.37 over the same period, giving you a clear sense of how top line and per share earnings are tracking into the latest release. With a trailing net profit margin of 12.8% versus 11.8% in the...
SEHK:86
SEHK:86Consumer Finance

Sun Hung Kai (SEHK:86) Half Year HK$887 Million Profit Challenges Bearish Margin Narratives

Sun Hung Kai (SEHK:86) has reported its FY 2025 first half with revenue of HK$1,929.8 million and basic EPS of HK$0.45, putting fresh numbers on the table for investors focused on earnings quality and payout capacity. The company has seen revenue move from HK$1,004.4 million and HK$1,019.5 million in the second and first halves of FY 2024 respectively to HK$1,929.8 million in the latest half. Basic EPS shifted from HK$0.04 and HK$0.15 across those periods to HK$0.45, against a backdrop of...
SEHK:2331
SEHK:2331Luxury

Li Ning (SEHK:2331) Margin Softness Tests Bullish Premiumisation Narrative

Latest FY 2025 results set the stage for Li Ning's next chapter Li Ning (SEHK:2331) has reported FY 2025 first half revenue of about C¥14.8b and basic EPS of C¥0.67, giving investors a fresh read on both top line scale and per share profitability. The company has seen revenue hold around the C¥14.3b to C¥14.8b range across the last three half year periods, while basic EPS shifted from C¥0.76 in 1H 2024 to C¥0.41 in 2H 2024 and C¥0.67 in 1H 2025. This sets up the current release as a check in...
SEHK:1919
SEHK:1919Shipping

COSCO Shipping Holdings (SEHK:1919) Margin Worsening Reinforces Bearish Earnings Narrative

COSCO SHIPPING Holdings (SEHK:1919) has wrapped up FY 2025 with fourth quarter revenue of C¥51.9b and basic EPS of C¥0.25. Trailing twelve month revenue came in at C¥219.5b with basic EPS of C¥1.99. Over the past few quarters, revenue has moved from C¥73.5b in Q3 2024 to C¥59.1b in Q4 2024 and then to C¥58.0b in Q1 2025 before landing at C¥51.9b in Q4 2025. Quarterly EPS shifted from C¥1.33 to C¥0.70 to C¥0.74 and then C¥0.25. With trailing net margin easing from 21% to 14.1%, the latest...
SEHK:836
SEHK:836Renewable Energy

China Resources Power Holdings (SEHK:836) Net Margin At 14.2% Tests Bearish Cash Flow Concerns

China Resources Power Holdings (SEHK:836) has just posted its FY 2025 results, with second half revenue of HK$51.7b, basic EPS of HK$1.28 and trailing twelve month EPS of HK$2.80 providing a clear snapshot of its recent earnings profile. Over the past few periods the company has seen half year revenue move from HK$54.2b in the second half of 2024 to HK$50.3b in the first half of 2025 and HK$51.7b in the second half of 2025, alongside basic EPS readings of HK$1.03, HK$1.52 and HK$1.28...
SEHK:1299
SEHK:1299Insurance

AIA Group (SEHK:1299) Margin Compression Challenges Bullish Profitability Narrative In FY 2025 Results

AIA Group (SEHK:1299) has just reported its FY 2025 results, with second half revenue of US$12.9 billion and basic EPS of US$0.35, while full year trailing twelve month revenue landed at US$26.2 billion and EPS at US$0.59. Over the past few periods, the company has seen revenue move from US$22.5 billion and EPS of US$0.62 in the twelve months to the second half of 2024, then to US$25.5 billion and EPS of US$0.56 by the first half of 2025, before reaching the latest trailing figures. This sets...
SEHK:2588
SEHK:2588Trade Distributors

BOC Aviation (SEHK:2588) Margin Decline Challenges Bullish Pricing Power Narrative

BOC Aviation (SEHK:2588) has reported its FY 2025 results with second half revenue of US$1.16b, basic EPS of US$0.64 and net income of US$445.7m. The trailing 12 month picture shows revenue of US$2.30b, basic EPS of US$1.13 and net income of US$787.2m, alongside a net margin of 34.3%, lower than the 43.1% recorded a year earlier. The company has seen revenue move from US$1.08b and basic EPS of US$0.67 in the second half of FY 2024 to US$1.16b and US$0.64 in the second half of FY 2025. The...
TSXV:IFOS
TSXV:IFOSChemicals

Itafos (TSXV:IFOS) Margin Improvement To 20.8% Tests Skepticism On Earnings Quality

Itafos (TSXV:IFOS) has put up another solid quarter, with Q3 FY 2025 revenue of US$152.8 million and basic EPS of US$0.19, backed by net income of US$36.2 million. Over recent periods the company has seen revenue move from US$119.99 million in Q3 FY 2024 to US$138.18 million in Q4 FY 2024 and then to US$152.8 million in Q3 FY 2025. Quarterly EPS has tracked from US$0.10 in Q3 FY 2024 to US$0.15 in Q4 FY 2024 and into the US$0.19 range. With trailing 12 month net margin now sitting at 20.8%...
LSE:NWG
LSE:NWGBanks

NatWest Full Note Redemption Reshapes Debt Profile And Investor Focus

NatWest Group has announced the full redemption of all outstanding Notes issued under a specified trust deed. The redemption will retire these instruments under its debt financing arrangements, affecting the group’s overall debt profile. The action is framed as part of NatWest Group’s broader capital management decisions. For investors watching LSE:NWG, the move comes with the shares trading around £5.336 and following a mixed return profile. The stock shows a 23.1% gain over 1 year and...
SWX:GIVN
SWX:GIVNChemicals

Givaudan Showcases Front End Innovation As Shares Trade Below Targets

Givaudan, ticker SWX:GIVN, is participating in the Future Food-Tech San Francisco event. The company is highlighting its front end innovation capabilities, with its Head of Front End Innovation presenting. The event participation puts a spotlight on Givaudan's role in emerging food technology trends and potential collaboration opportunities. Givaudan enters this conference with its share price at CHF2,701.0 and a value score of 4, reflecting how some investors may currently view the stock...
TSX:MX
TSX:MXChemicals

Is It Too Late To Consider Methanex (TSX:MX) After Its Strong Share Price Rally?

If you are wondering whether Methanex at a last close of US$77.51 is still offering value or starting to look fully priced, you are not alone. The share price move includes a 2.0% decline over the last 7 days, a 18.9% gain over 30 days, a 38.5% gain year to date, and a 43.9% gain over 1 year. These changes can influence how investors think about both upside and risk. Recent news around Methanex has focused on its position in the global methanol market and ongoing scrutiny of capital...